Abstract:Eleven-nineteen leukemia (ENL) protein is a histone acetylation reader essential for disease maintenance in acute leukemias, in particular, the mixed-lineage leukemia (MLL)-rearranged leukemia. In this study, we carried out high-throughput screening of a small-molecule library to identify inhibitors for the ENL YEATS domain. Structure–activity relationship studies of the hits and structure-based inhibitor design led to two compounds, 11 and 24, with IC50 values below 100 nM in inhibiting the ENL–acetyl-H3 interaction. Both compounds, and their precursor compound 7, displayed strong selectivity toward the ENL YEATS domain over all other human YEATS domains. Moreover, 7 exhibited on-target inhibition of ENL in cultured cells and a synergistic effect with the bromodomain and extraterminal domain inhibitor JQ1 in killing leukemia cells. Together, we have developed selective chemical probes for the ENL YEATS domain, providing the basis for further medicinal chemistry-based optimization to advance both basic and translational research of ENL.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.1c00367?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00367</a>.Overview of screen assay development, IC50 of top compounds, SPR and NMR data, cell growth inhibition, cell permeability assay, CETSA result of 7 in HeLa, qRT-PCR data, synergistic effect of 7 and JQ1 in MV4-11, molecular docking models of compounds bound to AF9 and ENL YEATS domains, HPLC traces for lead compounds, and table of the structure and IC50 of compounds from HTS with IC50 below 5 μM (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00367/suppl_file/jm1c00367_si_001.pdf">PDF</a>)Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00367/suppl_file/jm1c00367_si_002.csv">CSV</a>)Docking models (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00367/suppl_file/jm1c00367_si_003.zip">ZIP</a>)This article has not yet been cited by other publications.

Discovering potential inhibitors of YEATS domain of YEATS2 through virtual screening, molecular optimization and molecular dynamics simulation

Structure-guided Development of YEATS Domain Inhibitors by Targeting Π-Π-π Stacking

Structure-guided development of YEATS domain inhibitors by targeting pi-pi-pi stacking.

Selective Targeting of AF9 YEATS Domain by Cyclopeptide Inhibitors with Preorganized Conformation.

Discovery of Selective Small-Molecule Inhibitors for the ENL YEATS Domain

Fragment-Based Discovery of AF9 YEATS Domain Inhibitors

Discovering inhibitors of TEAD palmitate binding pocket through virtual screening and molecular dynamics simulation

Structural insights into the π-π-π stacking mechanism and DNA-binding activity of the YEATS domain

Computer-assisted Discovery and Evaluation of Potential Ribosomal Protein S6 Kinase Beta 2 Inhibitors

Discovery of selective ACAT2 antagonist via a combination strategy based on deep docking, pharmacophore modelling, and molecular dynamics simulation

Discovery of Potential WEE1 Inhibitors Via Hybrid Virtual Screening

Crucial Structural Understanding for Selective HDAC8 Inhibition: Common Pharmacophores, Molecular Docking, Molecular Dynamics, and Zinc Binder Analysis of selective HDAC8 inhibitors

Structural Simulation and Selective Inhibitor Discovery Study for Histone Demethylases KDM4E/6B from a Computational Perspective

Identification of Novel Inhibitors Targeting SGK1 via Ensemble-Based Virtual Screening Method, Biological Evaluation and Molecular Dynamics Simulation

Pharmacophore Modeling, Multiple Docking, and Molecular Dynamics Studies on Wee1 Kinase Inhibitors

Leveraging the Fragment Molecular Orbital and MM-GBSA Methods in Virtual Screening for the Discovery of Novel Non-Covalent Inhibitors Targeting the TEAD Lipid Binding Pocket

Deciphering Cathepsin K inhibitors: a combined QSAR, docking and MD simulation based machine learning approaches for drug design

Identification of Novel Smyd1 Inhibitors for Cardiovascular Disease Treatment through Molecular Modelling

Computational insights into inhibiting EphA2: Integrating structure-based virtual screening, docking, and molecular dynamics simulations for small molecule discovery

Chemical Inhibition of ENL/AF9 YEATS Domains in Acute Leukemia

Discovery of a Novel Acetylcholinesterase Inhibitor by Structure-Based Virtual Screening Techniques